Literature DB >> 21372811

Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells.

Kyung-Dal Choi1, Maxim Vodyanik, Igor I Slukvin.   

Abstract

In this paper, we describe a protocol for hematopoietic differentiation of human pluripotent stem cells (hPSCs) and generation of mature myeloid cells from hPSCs through expansion and differentiation of hPSC-derived lin(-)CD34(+)CD43(+)CD45(+) multipotent progenitors. The protocol comprises three major steps: (i) induction of hematopoietic differentiation by coculture of hPSCs with OP9 bone marrow stromal cells; (ii) short-term expansion of multipotent myeloid progenitors with a high dose of granulocyte-macrophage colony-stimulating factor; and (iii) directed differentiation of myeloid progenitors into neutrophils, eosinophils, dendritic cells, Langerhans cells, macrophages and osteoclasts. The generation of multipotent hematopoietic progenitors from hPSCs requires 9 d of culture and an additional 2 d to expand myeloid progenitors. Differentiation of myeloid progenitors into mature myeloid cells requires an additional 5-19 d of culture with cytokines, depending on the cell type.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372811      PMCID: PMC3066067          DOI: 10.1038/nprot.2010.184

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  29 in total

1.  Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation.

Authors:  Elizabeth S Ng; Richard P Davis; Lisa Azzola; Edouard G Stanley; Andrew G Elefanty
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

2.  Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development.

Authors:  Caihong Qiu; Eric Hanson; Emmanuel Olivier; Mari Inada; Dan S Kaufman; Sanjeev Gupta; Eric E Bouhassira
Journal:  Exp Hematol       Date:  2005-12       Impact factor: 3.084

3.  Feeder-independent culture of human embryonic stem cells.

Authors:  Tenneille E Ludwig; Veit Bergendahl; Mark E Levenstein; Junying Yu; Mitchell D Probasco; James A Thomson
Journal:  Nat Methods       Date:  2006-08       Impact factor: 28.547

4.  Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development.

Authors:  Elias T Zambidis; Bruno Peault; Tea Soon Park; Fred Bunz; Curt I Civin
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

5.  Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function.

Authors:  M Gaur; T Kamata; S Wang; B Moran; S J Shattil; A D Leavitt
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Hematopoietic colony-forming cells derived from human embryonic stem cells.

Authors:  D S Kaufman; E T Hanson; R L Lewis; R Auerbach; J A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

8.  T lineage differentiation from human embryonic stem cells.

Authors:  Zoran Galic; Scott G Kitchen; Amelia Kacena; Aparna Subramanian; Bryan Burke; Ruth Cortado; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

9.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

10.  Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

Authors:  Maxim A Vodyanik; Jack A Bork; James A Thomson; Igor I Slukvin
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

View more
  73 in total

1.  Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.

Authors:  Mark P Chao; Andrew J Gentles; Susmita Chatterjee; Feng Lan; Andreas Reinisch; M Ryan Corces; Seethu Xavy; Jinfeng Shen; Daniel Haag; Soham Chanda; Rahul Sinha; Rachel M Morganti; Toshinobu Nishimura; Mohamed Ameen; Haodi Wu; Marius Wernig; Joseph C Wu; Ravindra Majeti
Journal:  Cell Stem Cell       Date:  2017-01-12       Impact factor: 24.633

Review 2.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

Review 3.  Advances in cellular technology in the hematology field: What have we learned so far?

Authors:  Gustavo Torres de Souza; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Danielle Luciana Aurora Soares do Amaral; Francisco Carlos da Guia; Rafaella de Souza Salomão Zanette; João Vitor Paes Rettore; Natana Chaves Rabelo; Lucas Mendes Nascimento; Ícaro França Navarro Pinto; Júlia Boechat Farani; Abrahão Elias Hallack Neto; Fernando de Sá Silva; Carlos Magno da Costa Maranduba; Angelo Atalla
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

4.  Expression of coxsackievirus and adenovirus receptor separates hematopoietic and cardiac progenitor cells in fetal liver kinase 1-expressing mesoderm.

Authors:  Katsuhisa Tashiro; Nobue Hirata; Atsumasa Okada; Tomoko Yamaguchi; Kazuo Takayama; Hiroyuki Mizuguchi; Kenji Kawabata
Journal:  Stem Cells Transl Med       Date:  2015-03-11       Impact factor: 6.940

Review 5.  Progress towards generation of human haematopoietic stem cells.

Authors:  Lara Wahlster; George Q Daley
Journal:  Nat Cell Biol       Date:  2016-10-10       Impact factor: 28.824

6.  GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells.

Authors:  Kenji Kitajima; Marino Nakajima; Mai Kanokoda; Michael Kyba; Abhijit Dandapat; Jakub Tolar; Megumu K Saito; Masashi Toyoda; Akihiro Umezawa; Takahiko Hara
Journal:  Exp Hematol       Date:  2015-10-23       Impact factor: 3.084

7.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

Review 8.  The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.

Authors:  Katja G Weinacht; Patrick M Brauer; Kerstin Felgentreff; Alex Devine; Andrew R Gennery; Silvia Giliani; Waleed Al-Herz; Axel Schambach; Juan Carlos Zúñiga-Pflücker; Luigi D Notarangelo
Journal:  Curr Opin Immunol       Date:  2012-07-25       Impact factor: 7.486

9.  Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.

Authors:  Caroline Palmeira dos Santos; Gustavo J S Pereira; Christiano M V Barbosa; Aron Jurkiewicz; Soraya S Smaili; Claudia Bincoletto
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

10.  A high-fat diet increases IL-1, IL-6, and TNF-α production by increasing NF-κB and attenuating PPAR-γ expression in bone marrow mesenchymal stem cells.

Authors:  Mayara Cortez; Luciana Simão Carmo; Marcelo Macedo Rogero; Primavera Borelli; Ricardo Ambrósio Fock
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.